日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer

Alliance A222001:奥昔布宁与安慰剂治疗接受雄激素剥夺疗法治疗前列腺癌患者潮热的疗效比较

Stish, Bradley J; Mazza, Gina L; Nauseef, Jones T; Humeniuk, Michael Sandon; Smith, Thomas J; Tofthagen, Cindy; Diaz Pardo, Dayssy Alexandra; Chay, Christopher; Huang, Andrew J; Naha, Kushal; Tagawa, Scott T; Chow, Selina; Ruddy, Kathryn J; Lustberg, Maryam B; Adams-Campbell, Lucile L; Novotny, Paul J; Loprinzi, Charles L

Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data

利用真实世界数据和NATALEE数据,基于机器学习预测HR+/HER2-早期乳腺癌远处复发风险和瑞博西尼治疗效果

Howard, Frederick M; Fasching, Peter A; Santa-Maria, Cesar A; Lim, Elgene; Sparano, Joseph A; Lustberg, Maryam B; Bachelot, Thomas; Blyuss, Oleg; Brezden-Masley, Christine; Park, Yeon Hee; Akdere, Murat; Ye, Fen; Pantoja, Kristyn; Kurz, Christoph; Dominguez Castro, Patricia; Razavi, Pedram

Dance-based avenues to advance nonpharmacologic treatment of chemotherapy effects (DAANCE): study protocol for a multi-center, randomized controlled trial

利用舞蹈疗法促进化疗副作用的非药物治疗(DAANCE):一项多中心随机对照试验的研究方案

Luciani, Bhillie D; Alwan, Aya; Carlson, Martha; McNally, Gretchen; Hackney, Madeleine E; Crasta, Jewel E; Schnell, Patrick; Lustberg, Maryam B; Worthen-Chaudhari, Lise

Chemotherapy-induced neuropathy (CIN) persists chronically for most individuals with breast cancer who develop the condition: A survey study

一项调查研究显示,大多数患有化疗诱发性神经病变(CIN)的乳腺癌患者,其病情会持续存在,且为慢性:

Worthen-Chaudhari, Lise; Lustberg, Maryam B; Luciani, Bhillie D; Gatti-Mays, Margaret E; Sardesai, Sagar D; Davenport, Ashley P; Schnell, Patrick M

Screening History, Stage at Diagnosis, and Mortality in Screen-Detected Breast Cancer

筛查史、诊断分期和筛查发现的乳腺癌死亡率

Huang, Sida; Westvold, Sarah J; Soulos, Pamela R; Fan, Jane; Winer, Eric P; Zhan, Haiying; Lustberg, Maryam B; Lewin, John; Robinson, Timothy J; Dinan, Michaela A

Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis

曲妥珠单抗德鲁西替康与沙妥珠单抗戈维替康在HER2阴性转移性乳腺癌中的比较:一项大型真实世界数据分析

Sledge, George W Jr; Xiu, Joanne; Solzak, Jeffrey Peter; Ribeiro, Jennifer; Mahtani, Reshma L; Lustberg, Maryam B; Oberley, Matthew J; Radovich, Milan; Spetzler, David

Clinical, Sociodemographic, and Facility-Related Factors Influencing HER2-Targeted Therapy in Metastatic Hormone Receptor-Negative, HER2-Positive Breast Cancer

影响转移性激素受体阴性、HER2阳性乳腺癌HER2靶向治疗的临床、社会人口学和医疗机构相关因素

Ajjawi, Ismail; Rios, Alejandro; Wei, Wei; Park, Tristen S; Lustberg, Maryam B

Prognostic Value of Circulating Tumor DNA in HR+/HER2- Stage I-III Breast Cancer: A Systematic Review

循环肿瘤DNA在HR+/HER2- I-III期乳腺癌中的预后价值:系统评价

Ajjawi, Ismail; Rozenblit, Mariya; Rios-Hoyo, Alejandro; Lustberg, Maryam B

Clinical perspective on management of key adverse events with sacituzumab govitecan

关于使用sacituzumab govitecan治疗主要不良事件的临床管理视角

Tolaney, Sara M; Sonpavde, Guru P; Tarantino, Paolo; Lustberg, Maryam B; Rugo, Hope S

OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility

OATP1B型转运功能是芳香化酶抑制剂相关关节痛易感性的决定因素

Taheri, Hanieh; Li, Yang; Huang, Kevin M; Ahmed, Eman; Jin, Yan; Drabison, Thomas; Yang, Yan; Kulp, Samuel K; Young, Nicholas A; Li, Junan; Cheng, Xiaolin; Corps, Kara N; Coss, Christopher C; Vaughn, Jennifer E; Lustberg, Maryam B; Sparreboom, Alex; Hu, Shuiying